Daewoong pharmaceutical Co.,Ltd
Daewoong pharmaceutical Co.,Ltd (KRX: 069620) is trading at ₩108,500.00, about ₹7,831 at today's KRW/INR rate, as of 8 Oct 2026, 2:30 AM ET, down 1.72% today. Daewoong pharmaceutical is not currently available to trade on Paasa; this page shows its price, statistics and the Indian tax treatment for information.
Quote
Today's low
₩107,400.00
Today's high
₩110,600.00
52 week low
₩104,900.00
52 week high
₩199,400.00
069620 opened at ₩108,500.00, closed previously at ₩110,400.00, and has traded between ₩104,900.00 and ₩199,400.00 over the past 52 weeks.
About
Established in 1945 and headquartered in Seoul, South Korea, Daewoong Pharmaceutical Co., Ltd. is a global entity dedicated to the research, production, and international distribution of a diverse range of pharmaceutical products. Its extensive portfolio provides therapeutic solutions across numerous health disciplines, including treatments for central nervous system disorders, endocrine conditions, musculoskeletal ailments, nephrological issues, oncology, cardiovascular diseases, gastrointestinal complaints, and metabolic dysfunctions. The company further offers products addressing viral infections, pain relief, antacids, digestive problems, wound care, and nutritional supplements such as iron and multivitamins. Complementing its pharmaceutical offerings, Daewoong also supplies medical devices, notably COVID-19 PCR and IgG/IgM RDT diagnostic kits, along with viral transport media.
Key statistics
Avg. volume
34.08K
Market cap
₩1.25T
P/E Ratio
6.39
Price-to-sales ratio
0.76
Enterprise value
₩2.66T
Free cash flow yield
-2.12%
Debt-to-equity ratio
0.87
Return on equity
19.47%
ROIC
9.52%
Beta
0.01
Dividend yield
0.55%
Last dividend
₩600.00
Financial overview
Revenue
₩1.57T
Earnings per share
₩17,021.00
Free cash flow
-₩42.33B
Net profit margin
11.95%
Gross margin
51.59%
EBITDA
₩245.78B
Revenue growth
10.42%
Similar securities
This is not an investment recommendation
Daewoong pharmaceutical for Indian investors
Daewoong pharmaceutical is listed on the Korea Exchange. It is not currently available to trade on Paasa; the figures on this page are for information, and the tax notes below apply to Indian residents who hold it.
Taxes on Daewoong pharmaceutical for Indian residents
Trading and limits
- Trading hours
- 9:00 am – 3:30 pm KST
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- Slab rateDividends are taxed at your slab rate in India. Daewoong pharmaceutical’s current yield is 0.55%.Dividend tax explained
FAQs
Can I buy Daewoong pharmaceutical on Paasa?
Daewoong pharmaceutical (069620) has been listed on the Korea Exchange since 2005, in the Drug Manufacturers - Specialty & Generic industry. Daewoong pharmaceutical is not currently available to trade on Paasa; the figures on this page are for information. Indian residents who hold it through another broker still declare it under the rules below.
How much does one Daewoong pharmaceutical share cost in rupees?
One Daewoong pharmaceutical share is ₩108,500.00 — about ₹7,831 at a KRW/INR rate of 0.0722 on 8 Oct 2026. Both the Daewoong pharmaceutical price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for investing abroad from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability.
How are gains on Daewoong pharmaceutical shares taxed in India?
Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the KRW/INR rate on the purchase and the sale date, so the rupee move counts alongside the Daewoong pharmaceutical price.
Does Daewoong pharmaceutical pay a dividend, and how is it taxed in India?
Yes. Daewoong pharmaceutical pays a dividend and the current yield is 0.55%; the last declared dividend was ₩600.00 per share, about ₹43.30. Dividends are taxed at your slab rate in India.
When does KRX trade, in Indian time?
The Korea Exchange trades 5:30 am – 12:00 pm IST in Indian time.
Do I have to declare Daewoong pharmaceutical shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. The holding is reported with its cost and its closing value.
Does the rupee rate affect what I make on Daewoong pharmaceutical?
Yes. Daewoong pharmaceutical is priced in KRW, so your rupee outcome combines the KRW move with the KRW/INR move between the day you remit and the day you convert back.